Joseph L. Evans, Ph.D., is Executive Manager, Research and Development, Stratum Nutrition (Saint Charles, MO, USA), and a Novus International Science Fellow. Dr. Evans holds a Ph.D. in Biochemistry from Drexel University, and received post-doctoral training in physiology and pharmacology at Dartmouth Medical School and the Panum Institute. Dr. Evans’ translational research experience extends from mechanistic research through randomized, controlled, clinical trials, and has successfully focused on the discovery and commercialization of pharmacological and nutritional interventions for the metabolic and cardiovascular diseases. Dr. Evans has published approximately 80 peer-reviewed scientific papers, review articles, book chapters, abstracts, and US patents.

Dr. Hoffman obtained his medical degree (M.D.) from The Ohio State University College of Medicine. He did his pediatric residency at the Akron Children’s Hospital and his pediatric endocrinology fellowship at Children’s Hospital of Pittsburgh. He is currently a Professor of Pediatrics and Program Director for the Pediatric Endocrinology Fellowship at Nationwide Children’s Hospital and The Ohio State University. His research interests are type 1 diabetes, hypoglycemia and the cardiovascular endocrinology.

Dr. Qi obtained a medical degree in China and PhD at Tufts University in the United States. He is now HCA Regents Distinguished Chair and Professor in Tulane University and Adjunct Professor at Harvard T.H Chan School of Public Health. He has published more than 210 scientific publications and edited a textbook.

Dr. Hernaez-Ortega obtained a doctorate (Ph.D.) in Ophthalmology from the University of Valladolid (Spain), and completed her training in vitreoretinal surgery at the Bascom Palmer Eye Institute (Miami, USA) and the Jules Stein Eye Institute (Los Angeles, USA). Dr. Hernaez-Ortega is a member of the Spanish Retina and Vitreous Society (SERV) and the European Society of Retina Specialists (EURETINA). She has nearly 20 years of experience in the research and medical-surgical treatment of diabetic eye complications. Dr. Hernaez-Ortega has authored and co-authored more than 30 scientific manuscripts and book chapters.

Dr. Sil is currently a senior professor and research coordinator of the “Molecular Medicine” program of Bose Institute, Calcutta, India. He has more than 25 years of research experience in several major areas of chemicals, drugs as well as environmentally exposed nanostructure-induced and oxidative stress mediated organ pathophysiology. Previously, Dr. Sil served as the “Head” of the Division of Molecular Medicine at Bose Institute. Dr. Sil holds a Ph.D. degree in Chemistry from the University of Calcutta and conducted Postdoctoral research at the Cleveland Clinic Foundation, Cleveland, Ohio, USA. Dr. Sil authored more than 130 manuscripts and 8 book chapters; serving as reviewers of more than 170 journals, an Associate Editor of “Toxicology Reports” and an Editorial Board Member of “Heliyon”.

Dr. Rosa Corcoy graduated in Medicine in 1982 at Universitat Autònoma de Barcelona, Spain with highest honors. She is currently the Director of the Diabetes Unit at Hospital de la Santa Creu i Sant Pau in Barcelona, Aggregate Professor of the Department of Medicine of the Universitat Autònoma de Barcelona and member of the CIBER-BBN, Zaragoza.

She is a clinical endocrinologist and her research has focused in endocrinological conditions & pregnancy and Type 1 diabetes mellitus. She is author or co-author or more than 100 articles and 40 book chapters. She has received several awards, among them the José Luis Rodriguez Miñón, Sociedad Española de Diabetes in 2010 and the Jorgen Pedersen Award, Diabetic Pregnancy Study Group-EASD in 2012.

She has served in the Board of Associació Catalana de Diabetes, Societat Catalana d’Endocrinologia, Sociedad Española de Diabetes, Grupo Español de Diabetes y Embarazo and Diabetic Pregnancy Study Group-DPSG.

Dr Gazzaruso is Head of the Diabetes and Endocrine-metabolic disease Unit, of the Emergency Unit and of the Center for Applied Clinical Research (Ce.R.C.A.) at Clinical Institute “Beato Matteo”, Vigevano, Italy of the Hospital Group San Donato. He is certified specialist and PhD in Internal Medicine and has a Master on type 2 diabetes. He was specialist and researcher at Maugeri Foundation, Pavia, Italy and consultant in Internal Medicine, Endocrinology and Cardiology at Mondino Foundation, Pavia, Italy. He has the National Scientific Qualification as an Associate Professor of Endocrinology. From 1997 he acts as a contract professor at the University of Pavia. He is authors of more than 90 peer-reviewed articles.

Prof. Anoop Misra is the Chairman, Fortis-CDOC Center of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, New Delhi, India and has been a faculty at the Department of Endocrinology at the Southwestern Medical Center in Dallas, Texas, USA, and All India Institute of Medical Sciences, New Delhi. He has lead consensus guidelines for obesity, the metabolic syndrome, physical activity, and diets for Asian Indians. His current research includes fatty liver and fatty pancreas in relation to insulin resistance and diabetes. He has been awarded highest award for medicine in India Dr BC Roy award (2006) and prestigious Indian National Honor, Padma Shree (2007).

Dr. Yorek obtained a doctorate (Ph.D.) in Biochemistry from the University of North Dakota. Currently Dr. Yorek is a Professor in the Division of Endocrinology and Metabolism in the Department of Internal Medicine at the College of Medicine at the University of Iowa. He is also the Associate Chief of Staff at the Iowa City VA Medical Center. His research interest includes vascular and neural complications of obesity and diabetes. He has published more than 140 scientific peer reviewed publications.

Professor Ernest Adeghate obtained his medical degree from Semmelweis University Medical School, Budapest, Hungary and his PhD and DSc from the Hungarian Academy of Sciences. He also has a Master degree in Family Medicine from Monash University, Australia. He is interested in the morphology of pancreatic grafts and the effect of neurotransmitters, neuropeptides and cytokines on parameters of metabolic disease, insulin release and on complications of diabetes mellitus. Prof. Adeghate has published more than 200 peer-reviewed articles. He is currently, the Editor-in Chief of The Open Medicinal Chemistry Journal published by Bentham Science Publishers.

Specialist in Internal Medicine and Endocrinology, graduated from the Instituto Nacional de Ciencias Medicas y Nutricion. Doctor of Clinical Investigation. Research follow at the Washington University. School of Medicine. He has published 275 articles in indexed journals. Member of the Mexican National Academy of Medicine. Former president of the Mexican Society of Nutrition and Endocrinology (2009). His work has contributed to describe the epidemiology and genetics of type 2 diabetes and dyslipidemias in Mexicans.

Fabio Angeli is a Cardiologist and Biomedical researcher trained in cardiovascular medicine, particularly in the context of cardiovascular risk assessment, diabetes, kidney diseases, heart failure, acute coronary syndromes and maternal and neonatal healthcare. He has published more than 160 papers in reputed journals indexed by PubMed and has been serving as an editorial board member of several international leading Journals.

Dr. Lu Cai received his MD and a Ph.D. in Radiation Biology/Oncology from Jilin University (formally Norman Bethune University of Medical Sciences), Changchun, P.R. China. He also holds the appointment as Visiting Professor at Jilin University and Wenzhou Medical University. Dr. Cai is currently a tenured Professor, with appointments in the departments of Pediatrics, Radiation Oncology and Pharmacology, and Toxicology. Dr. Cai was also appointed as Director of Kosair Children’s Hospital Research Institute, the University of Louisville School of Medicine. He has published more than 210 in the field of diabetes and its complications. Currently, Dr. Cai serves as Associate Editor of Toxicological Science, and was Senior Editor for Journal of Geriatric Cardiology and Journal of Diabetes Research and Clinical Metabolism

Dr. Dandona is a Distinguished Professor of Medicine and chief of the Division of Endocrinology, Diabetes and Metabolism, at the University at Buffalo, The State University of New York, and the founder of the Diabetes–Endocrinology Center of Western New York in Buffalo. Dr. Dandona is a Rhodes Scholar from India, trained at the University of Oxford and the University of London. Dr. Dandona has published more than 540 papers in peer-reviewed medical journals, and has presented keynote lectures on diabetes and insulin resistance at many national and international conferences

Dr. Gu’s education background includes VMD (Nanjing, China 1982), MSc in Pathology (Nanjing, China 1988) and PhD in Genetics (Uppsala, Sweden 1994). Currently, he is an Associate Professor in Molecular Genetics, Karolinska Institutet, Stockholm, Sweden. His research interests are mainly focused on molecular medicine and translation medicine in diabetes, obesity and diabetic nephropathy. He has published over 120 peer-reviewed articles in international journals and chapters in three books related with diabetes and diabetic nephropathy.

Dr. Hampe received her PhD at the Weizmann Institute of Science in Israel in 1997. She did her post-doctoral training in Dr. Åke Lernmark’s laboratory at the University of Washington, Seattle and is currently an Associate Professor at the Diabetes Research Institute at the University of Washington. She has 20 years of research experience focusing on autoimmune diseases including Type 1 diabetes and autoimmune neurological disorders. Dr. Hampe has authored over 100 manuscripts. She serves on study sections at the Juvenile Diabetes Research Foundation, the American Diabetes Association and NIH.

Dr. Kamoi obtained a doctorate (M.D.) on March 1970 in Medicine from theUniversity of Niigata, Japan. Dr. Kamoi also holed an research fellow in septeｍber 1977 to May to 1979 from the University of Indiana and Professor of Niigata University in April 2010 to March 2014. Currently, Dr. Kamoi is also an in the Director of Diabetes Mellitus & Disorders of hyothamic pituitary glands in Joetsu General Hospital, Japan. He has published more than 200 scientific publications .Dr. Kamoi was the editor of board members of Current Diabetes Review (2005) of this journal (Current Diabetes Review), published by Bentham Science Publishers.

Dr. ismail Laher is a Professor of Pharmacology and Therapeutics at the University of Pharmacology. He holds a degree in pharmacology from the University of London and graduate training in Canada and post-graduate training at the University of Vermont. Dr. Laher’s research interests are in vascular regulation (particularly of small arteries) in health and disease and the effects of exercise in improving endothelial function (e.g. in diabetes). More recent work focusses on the vascular function in rodent models of obstructive sleep apnea (especially in conjunction with underlying complications of diabetes / obesity).

Demosthenes Panagiotakos is Professor and vice Rector at the Harokopio University in Athens. He is also visiting Distinguished Professor at School of Arts and Sciences, Rutgers, the State University of New Jersey, US, visiting Professor at the School of Medicine, University of Athens and at the Agricultural University of Athens. He has published 3 books, 600+ papers (has >13.500 citations, h-index=55). He is Member of the Scientific Committee of Health, Environment and Emerging Risks of the European Committee, the Scientific Council of the Hellenic Food Authority, the National Council for Nutrition Policy and has served as Board Member of the National Council of Public Health.

Dr. Giuseppe Seghieri graduated with cum laude in medicine from the University of Florence, Italy. He did specialization with cum laude in Medical Toxicology (1978), in Gastroenterology (1982), in Clinical Pharmacology (1986), in Internal Medicine (1992) and in Endocrinology (2007). Dr. Seghieri has been Chief of hospital department of internal medicine at the Hospital of Pistoia, Italy for more than 20 years. He is a research fellow at the Regional Health Agency of Tuscany, Florence, Italy and also professor of Internal Medicine at the University of Florence (Chair of Physiotherapy). He is (co-) author of more than 150 papers mostly dealing with diabetes and its complications, cardiovascular diseases or gender medicine.

Dr. Nicola Troisi received his MD degree magna cum laude from the University “Federico II”, Naples, Italy. He attended the post-doctorate fellowship training at the University of Florence, Italy, and he obtained the title of Specialist in Vascular Surgery (magna cum laude with a final experimental study “New technical solutions for the endovascular treatment of aneurysms of abdominal aorta and of iliac arteries”). He was Clinical Research Fellow at the Department of Vascular Surgery, St. Franziskus Hospital, Münster, Germany and at the Department of Vascular and Endovascular Surgery, University Hospital, Münster, Germany. He authored and co-authored about 170 publications of which 82 published in peer-reviewed scientific journals.

Dr. Vinik is an international leader in basic and clinical neuropathy and neuroendocrine tumors, and isolated INGAP in clinical trials for “Curing” diabetes. He has authored ten books, 124 book chapters, and published more than 500 papers in highly reputable journals. Dr. Vinik received the Virginia Outstanding Scientist Award, was elected a Health Care Hero, received lifetime recognition for contributions to Neuropathy and a distinction in endocrinology. He has served NIH and ADA grant committees and funded by NIH, NIAA, ADA and industry. He holds patents for INGAP and copyrights for the Norfolk Quality of Life DN and NET tools.

Dr. Prasant Kumar Jena received his BSc in Biological Sciences and MSc in Biotechnology from Berhampur University. Later, he obtained a Ph.D. in Biotechnology from Nirma University (India). He has more than 9 years of research experience in studying the impact of diet and gut microbiota on the development of metabolic diseases including obesity, diabetes, and carcinogenesis. In his graduate studies, he developed a sugar diet-induced diabetes rat model to study the effect of microbiota and probiotic intervention in lipid and carbohydrate metabolism. Currently, Dr. Jena is working at University of California Davis as a researcher.